Zealand Pharma CEO: Zegalogue launch continues as planned

It's nearly two months back since last June when Zealand Pharma launched its hypoglycemia medication, Zegalogue, on the US market. According to the Danish biotechnology group's chief executive, Emmanuel Dulac, everything is going completely according to plan.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Zealand Pharma sends blood sugar drug to US market
For subscribers